Metabonomic profiling in studying anti-osteoporosis effects of strontium fructose 1,6-diphosphate on estrogen deficiency-induced osteoporosis in rats by GC/TOF-MS

European Journal of Pharmacology

Volumn 718, Issue 1-3, 2013, Pages 524-532

  Ma, Bo ^a   Li, Xiaotian ^b   Zhang, Qi ^a   Wu, Di ^c   Wang, Guangji ^d   Jiye, A ^d   Sun, Jianguo ^d   Li, Jing ^a   Liu, Yinhui ^a   Wang, Yonglu ^a   Ying, Hanjie ^a  

^a NANJING TECH UNIVERSITY   (China)

^b ZHENGZHOU UNIVERSITY   (China)

^c UNIVERSITY OF PENNSYLVANIA   (United States)

^d CHINA PHARMACEUTICAL UNIVERSITY   (China)

Author keywords

6 diphosphate (FDP Sr); GC TOF MS; Metabonomic; Osteoporosis; Strontium fructose 1

Indexed keywords

ALANINE; ARACHIDONIC ACID; BIOLOGICAL MARKER; DOCOSAHEXAENOIC ACID; GLYCERIC ACID; HOMOCYSTEINE; HYDROXYPROLINE; OCTADECADIENOIC ACID; OLEIC ACID; PALMITIC ACID; STRONTIUM; STRONTIUM FRUCTOSE 1,6 DIPHOSPHATE; UNCLASSIFIED DRUG; URIC ACID;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIOSTEOPOROSIS EFFECT; ARTICLE; BODY WEIGHT; BONE DENSITY; BONE METABOLISM; BONE TURNOVER; CONTROLLED STUDY; DISEASE COURSE; DRUG EFFECT; DRUG SAFETY; ESTROGEN DEFICIENCY; FEMALE; GAS CHROMATOGRAPHY; METABOLISM; METABONOMIC PROFILING; NONHUMAN; ORGAN WEIGHT; OSTEOLYSIS; OSTEOPOROSIS; PRIORITY JOURNAL; RAT; TIME OF FLIGHT MASS SPECTROMETRY;

6-DIPHOSPHATE (FDP-SR); GC/TOF-MS; METABONOMIC; OSTEOPOROSIS; STRONTIUM FRUCTOSE 1;

ANIMALS; BIOLOGICAL MARKERS; BODY WEIGHT; BONE DENSITY; ESTROGENS; FEMALE; FRUCTOSEDIPHOSPHATES; GAS CHROMATOGRAPHY-MASS SPECTROMETRY; METABOLOMICS; ORGAN SIZE; OSTEOPOROSIS; RATS; RATS, SPRAGUE-DAWLEY;

EID: 84887057928     PISSN: 00142999     EISSN: 18790712     Source Type: Journal    
DOI: 10.1016/j.ejphar.2013.06.030     Document Type: Article

References (41)

1. J. A, J. Trygg, J. Gullberg, A.I. Johansson, P. Jonsson, H. Antti, S.L. Marklund, and T. Moritz Extraction and GC/MS analysis of the human blood plasma metabolome Anal. Chem. 77 2005 8086 8094 (Pubitemid 43000566)
2. J. A, S. Qian, G. Wang, B. Yan, S. Zhang, Q. Huang, L. Ni, W. Zha, L. Liu, B. Cao, M. Hong, H. Wu, H. Lu, J. Shi, M. Li, and J. Li Chronic myeloid leukemia patients sensitive and resistant to imatinib treatment show different metabolic responses PLoS One 5 2010 e13186
3. T. Akamine, W.S. Jee, H.Z. Ke, X.J. Li, and B.Y. Lin Prostaglandin E2 prevents bone loss and adds extra bone to immobilized distal femoral metaphysis in female rats Bone 13 1992 11 22
4. I. Bayhan, D. Uygur, N. Ugurlu, and G. Ozaksit Strontium ranelate decreases plasma homocysteine levels in postmenopausal osteoporotic women Rheumatol. Int. 29 2009 263 266
5. E. Bonnelye, A. Chabadel, F. Saltel, and P. Jurdic Dual effect of strontium ranelate: stimulation of osteoblast differentiation and inhibition of osteoclast formation and resorption in vitro Bone 42 2008 129 138 (Pubitemid 350297175)
6. J. Caverzasio Strontium ranelate promotes osteoblastic cell replication through at least two different mechanisms Bone 42 2008 1131 1136
7. N. Chattopadhyay, S.J. Quinn, O. Kifor, C. Ye, and E.M. Brown The calcium-sensing receptor (CaR) is involved in strontium ranelate-induced osteoblast proliferation Biochem. Pharmacol. 74 2007 438 447 (Pubitemid 46970843)
8. K.R. Dimitrova, K. DeGroot, A.K. Myers, and Y.D. Kim Estrogen and homocysteine Cardiovasc. Res. 53 2002 577 588 (Pubitemid 34175250)
9. M. Durand, M.A. Gallant, and A.J. de Brum-Fernandes Prostaglandin D2 receptors control osteoclastogenesis and the activity of human osteoclasts J. Bone Miner. Res. 23 2008 1097 1105 (Pubitemid 351915732)
10. O. Fromigue, E. Hay, A. Barbara, and P.J. Marie Essential role of nuclear factor of activated T cells (NFAT)-mediated Wnt signaling in osteoblast differentiation induced by strontium ranelate J. Biol. Chem. 285 2010 25251 25258
11. C. Garcia, B.F. Boyce, J. Gilles, M. Dallas, M. Qiao, G.R. Mundy, and L.F. Bonewald Leukotriene B4 stimulates osteoclastic bone resorption both in vitro and in vivo J. Bone Miner. Res. 11 1996 1619 1627 (Pubitemid 26367672)
12. J.L. Griffin Metabonomics: NMR spectroscopy and pattern recognition analysis of body fluids and tissues for characterisation of xenobiotic toxicity and disease diagnosis Curr. Opin. Chem. Biol. 7 2003 648 654 (Pubitemid 37315803)
13. H. Hikiji, T. Takato, T. Shimizu, and S. Ishii The roles of prostanoids, leukotrienes, and platelet-activating factor in bone metabolism and disease Prog. Lipid Res. 47 2008 107 126
14. J. Iwamoto, T. Takeda, Y. Sato, and J.K. Yeh Synergistic effect of vitamin K2 and prostaglandin E2 on cancellous bone mass in hypophysectomized young rats Calcif. Tissue Int. 79 2006 318 325 (Pubitemid 44900155)
15. W.S. Jee, T. Akamine, H.Z. Ke, X.J. Li, L.Y. Tang, and Q.Q. Zeng Prostaglandin E2 prevents disuse-induced cortical bone loss Bone 13 1992 153 159
16. P. Jonsson, A.I. Johansson, J. Gullberg, J. Trygg, J. A, B. Grung, S. Marklund, M. Sjostrom, H. Antti, and T. Moritz High-throughput data analysis for detecting and identifying differences between samples in GC/MS-based metabolomic analyses Anal. Chem. 77 2005 5635 5642 (Pubitemid 41268639)
17. M. Kanatani, T. Sugimoto, J. Kano, and K. Chihara IGF-I mediates the stimulatory effect of high phosphate concentration on osteoblastic cell proliferation J. Cell. Physiol. 190 2002 306 312 (Pubitemid 34111971)
18. I.A. Katz, W.S. Jee, I.I. Joffe, B. Stein, M. Takizawa, T.W. Jacobs, R. Setterberg, B.Y. Lin, L.Y. Tang, and H.Z. Ke Prostaglandin E2 alleviates cyclosporin A-induced bone loss in the rat J. Bone Miner. Res. 7 1992 1191 1200
19. M.M. Koek, v. der Kloet FM, R. Kleemann, T. Kooistra, E.R. Verheij, and T. Hankemeier Semi-automated non-target processing in GC x GC-MS metabolomics analysis: applicability for biomedical studies Metabolomics 7 2011 1 14
20. Y. Lu, J. A, G. Wang, H. Hao, Q. Huang, B. Yan, W. Zha, S. Gu, H. Ren, Y. Zhang, X. Fan, M. Zhang, and K. Hao Gas chromatography/time-of-flight mass spectrometry based metabonomic approach to differentiating hypertension- and age-related metabolic variation in spontaneously hypertensive rats Rapid Commun. Mass Spectrom. 22 2008 2882 2888
21. B. Ma, Q. Zhang, G. Wang, Z. Wu, J.P. Shaw, Y. Hu, Y. Wang, Y. Zheng, Z. Yang, and H. Ying Synthesis and pharmacokinetics of strontium fructose 1,6-diphosphate (Sr-FDP) as a potential anti-osteoporosis agent in intact and ovariectomized rats J. Inorg. Biochem. 105 2011 563 568
22. B. Ma, Q. Zhang, G.J. Wang, J.Y. A, D. Wu, Y. Liu, B. Cao, L.S. Liu, Y.Y. Hu, Y.L. Wang, and Y.Y. Zheng GC-TOF/MS-based metabolomic profiling of estrogen deficiency-induced obesity in ovariectomized rats Acta Pharmacol. Sin. 32 2011 270 278
23. B. Ma, Q. Zhang, D. Wu, Y.L. Wang, Y.Y. Hu, Y.P. Cheng, Z.D. Yang, Y.Y. Zheng, and H.J. Ying Strontium fructose 1,6-diphosphate prevents bone loss in a rat model of postmenopausal osteoporosis via the OPG/RANKL/RANK pathway Acta Pharmacol. Sin. 33 2012 479 489
24. R.R. McLean, P.F. Jacques, J. Selhub, K.L. Tucker, E.J. Samelson, K.E. Broe, M.T. Hannan, L.A. Cupples, and D.P. Kiel Homocysteine as a predictive factor for hip fracture in older persons N. Engl. J. Med. 350 2004 2042 2049 (Pubitemid 38596555)
25. P.J. Meunier, C. Roux, E. Seeman, S. Ortolani, J.E. Badurski, T.D. Spector, J. Cannata, A. Balogh, E.M. Lemmel, S. Pors-Nielsen, R. Rizzoli, H.K. Genant, and J.Y. Reginster The effects of strontium ranelate on the risk of vertebral fracture in women with postmenopausal osteoporosis N. Engl. J. Med. 350 2004 459 468 (Pubitemid 38133766)
26. H. Meves Arachidonic acid and ion channels: an update Br. J. Pharmacol. 155 2008 4 16
27. A. Mo, W. Yao, C. Li, X. Tian, M. Su, Y. Ling, Q. Zhang, R.B. Setterberg, and W.S. Jee Bipedal stance exercise and prostaglandin E2 (PGE2) and its synergistic effect in increasing bone mass and in lowering the PGE2 dose required to prevent ovariectomized-induced cancellous bone loss in aged rats Bone 31 2002 402 406 (Pubitemid 35299620)
28. J.K. Nicholson, and J.C. Lindon Systems biology: metabonomics Nature 455 2008 1054 1056
29. W. Qi, P.J. Wang, W.J. Guo, Y.B. Yan, Y. Zhang, and W. Lei The mechanism of Cordyceps sinensis and strontium in prevention of osteoporosis in rats Biol. Trace Elem. Res. 143 2011 302 309
30. R. Ramautar, O.A. Mayboroda, G.W. Somsen, and GJ de Jong CE-MS for metabolomics: developments and applications in the period 2008-2010 Electrophoresis 32 2011 52 65
31. G.O. Ramirez-Yanez, G.J. Seymour, L.J. Walsh, M.R. Forwood, and A.L. Symons Prostaglandin E2 enhances alveolar bone formation in the rat mandible Bone 35 2004 1361 1368 (Pubitemid 40260399)
32. P. Requirand, P. Gibert, P. Tramini, J.P. Cristol, and B. Descomps Serum fatty acid imbalance in bone loss: example with periodontal disease Clin. Nutr. 19 2000 271 276
33. S.M. Sacco, J.M. Jiang, S. Reza-Lopez, D.W. Ma, L.U. Thompson, and W.E. Ward Flaxseed combined with low-dose estrogen therapy preserves bone tissue in ovariectomized rats Menopause 16 2009 545 554
34. M.J.B. van, R.A. Dhonukshe-Rutten, S.M. Pluijm, v. der Klift M, R de Jonge, J. Lindemans, LC de Groot, A. Hofman, J.C. Witteman, L.J.P. van, M.M. Breteler, P. Lips, H.A. Pols, and A.G. Uitterlinden Homocysteine levels and the risk of osteoporotic fracture N. Engl. J. Med. 350 2004 2033 2041
35. B.A. Watkins, Y. Li, K.G. Allen, W.E. Hoffmann, and M.F. Seifert Dietary ratio of (n-6)/(n-3) polyunsaturated fatty acids alters the fatty acid composition of bone compartments and biomarkers of bone formation in rats J. Nutr. 130 2000 2274 2284
36. W. Weckwerth Metabolomics in systems biology Annu. Rev. Plant. Biol. 54 2003 669 689 (Pubitemid 37400009)
37. M. Weinreb, D. Shamir, M. Machwate, G.A. Rodan, S. Harada, and S. Keila Prostaglandin E2 (PGE2) increases the number of rat bone marrow osteogenic stromal cells (BMSC) via binding the EP4 receptor, activating sphingosine kinase and inhibiting caspase activity Prostaglandins Leukot. Essent. Fatty Acids 75 2006 81 90 (Pubitemid 44287469)
38. L.A. Weiss, E. Barrett-Connor, and M.D. von Ratio of n-6 to n-3 fatty acids and bone mineral density in older adults: the Rancho Bernardo Study Am. J. Clin. Nutr. 81 2005 934 938 (Pubitemid 41725005)
39. I.D. Wilson, R. Plumb, J. Granger, H. Major, R. Williams, and E.M. Lenz HPLC-MS-based methods for the study of metabonomics J. Chromatogr. B Anal. Technol. Biomed. Life Sci. 817 2005 67 76 (Pubitemid 40174790)
40. B. Yan, J. A, G. Wang, H. Lu, X. Huang, Y. Liu, W. Zha, H. Hao, Y. Zhang, L. Liu, S. Gu, Q. Huang, Y. Zheng, and J. Sun Metabolomic investigation into variation of endogenous metabolites in professional athletes subject to strength-endurance training J. Appl. Physiol. 106 2009 531 538
41. F. Yang, D. Yang, J. Tu, Q. Zheng, L. Cai, and L. Wang Strontium enhances osteogenic differentiation of mesenchymal stem cells and invivo bone formation by activating Wnt/catenin signaling Stem Cells 29 2011 981 991